was read the article
array:22 [ "pii" => "S1665268124002047" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101410" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.23" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S1665268124002059" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101411" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.24" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Hepatitis A at the Hospital de Especialidades Centro Medico Nacional La Raza. Preliminary report." "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Karenn Garcia-Campos, Christopher J. Toranzo-González, Carlos M. del Real-Calzada, Mauricio Castillo-Barradas, Francisca Martínez-Silva, María C. Bernardino-del Río, María C. Baxín-Domínguez, Federico U. Villegas-García, Viridiana Rodríguez-Granados, María T. Rizo-Robles" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Karenn" "apellidos" => "Garcia-Campos" ] 1 => array:2 [ "nombre" => "Christopher J." "apellidos" => "Toranzo-González" ] 2 => array:2 [ "nombre" => "Carlos M." "apellidos" => "del Real-Calzada" ] 3 => array:2 [ "nombre" => "Mauricio" "apellidos" => "Castillo-Barradas" ] 4 => array:2 [ "nombre" => "Francisca" "apellidos" => "Martínez-Silva" ] 5 => array:2 [ "nombre" => "María C." "apellidos" => "Bernardino-del Río" ] 6 => array:2 [ "nombre" => "María C." "apellidos" => "Baxín-Domínguez" ] 7 => array:2 [ "nombre" => "Federico U." "apellidos" => "Villegas-García" ] 8 => array:2 [ "nombre" => "Viridiana" "apellidos" => "Rodríguez-Granados" ] 9 => array:2 [ "nombre" => "María T." "apellidos" => "Rizo-Robles" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002059?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002059/v2_202404250742/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S1665268124002035" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101409" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.22" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Sword of Damocles: a hard blow from hepatitis A." "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jerónimo D. Galván-Rodríguez, Karla G. Fonseca-Castillo, Yolanda G. Nuño-Curiel, Melina Chaires-Navarro, Óscar H. Murillo-Robledo, Juan J. Morales-Reyes, María L. Guzmán-Ramírez, Kevin J. Arellano-Arteaga" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Jerónimo D." "apellidos" => "Galván-Rodríguez" ] 1 => array:2 [ "nombre" => "Karla G." "apellidos" => "Fonseca-Castillo" ] 2 => array:2 [ "nombre" => "Yolanda G." "apellidos" => "Nuño-Curiel" ] 3 => array:2 [ "nombre" => "Melina" "apellidos" => "Chaires-Navarro" ] 4 => array:2 [ "nombre" => "Óscar H." "apellidos" => "Murillo-Robledo" ] 5 => array:2 [ "nombre" => "Juan J." "apellidos" => "Morales-Reyes" ] 6 => array:2 [ "nombre" => "María L." "apellidos" => "Guzmán-Ramírez" ] 7 => array:2 [ "nombre" => "Kevin J." "apellidos" => "Arellano-Arteaga" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002035?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002035/v2_202404250742/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Retreatment experience with Glecaprevir/Pibrentasvir (G/P) for hepatitis C infection in patients failing first-line direct-acting antiviral agents." "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Orestes J. Cobos-Quevedo, Ximena E. Cuenca-Avila, Leonardo S. Juárez-Chávez, Mauricio Castillo-Barradas, Enrique Carrera-Estupiñan, José L. Pérez-Hernández, María F. Higuera-De la Tijera" "autores" => array:7 [ 0 => array:3 [ "nombre" => "Orestes J." "apellidos" => "Cobos-Quevedo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 1 => array:3 [ "nombre" => "Ximena E." "apellidos" => "Cuenca-Avila" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 2 => array:3 [ "nombre" => "Leonardo S." "apellidos" => "Juárez-Chávez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 3 => array:3 [ "nombre" => "Mauricio" "apellidos" => "Castillo-Barradas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">2</span>" "identificador" => "aff0002" ] ] ] 4 => array:3 [ "nombre" => "Enrique" "apellidos" => "Carrera-Estupiñan" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">3</span>" "identificador" => "aff0003" ] ] ] 5 => array:3 [ "nombre" => "José L." "apellidos" => "Pérez-Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 6 => array:3 [ "nombre" => "María F. Higuera-De" "apellidos" => "la Tijera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Gastroenterology and Hepatology department. General Hospital of Mexico "Dr. Eduardo Liceaga". Mexico city, Mexico" "etiqueta" => "1" "identificador" => "aff0001" ] 1 => array:3 [ "entidad" => "Gastroenterology department. Specialty Hospital Dr. Antonio Fraga Mouret, La Raza National Medical Center. Mexico city, Mexico" "etiqueta" => "2" "identificador" => "aff0002" ] 2 => array:3 [ "entidad" => "Gastroenterology department. Specialty Hospital "Eugenio Espejo". Quito, Ecuador" "etiqueta" => "3" "identificador" => "aff0003" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="para0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Ethical statement</span></p><p id="para0006" class="elsevierStylePara elsevierViewall">The protocol was registered and approved by the Ethics Committee. The identity of the patients is protected. Consentment was obtained.</p><p id="para0007" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Declaration of interests</span></p><p id="para0008" class="elsevierStylePara elsevierViewall">None</p><p id="para0009" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Funding</span></p><p id="para0010" class="elsevierStylePara elsevierViewall">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0001">Introduction and Objectives</span><p id="spara001" class="elsevierStyleSimplePara elsevierViewall">First-line direct-acting antiviral agents (DAAs) achieved a sustained viral response (SVR) in >95%, failure to follow the scheme is rare and the option of retreatment with sofosbuvir/velpatasvir/voxilaprevir does not exist in our setting, therefore although G/P is considered an alternative, it is the only available option. There are few reports evaluating it; due to this, we describe the frequency and characteristics of patients with failure to first-line DAA schemes and the result of retreatment with G/P during the period from January 2017 to January 2023 in 3 tertiary hospital centers.</p></span> <span id="abss0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0002">Materials and Patients</span><p id="spara002" class="elsevierStyleSimplePara elsevierViewall">The intentional search for cases with failure to achieve SVR with first-line DAAs was carried out in 2 Mexican reference centers and one Ecuadorian center during the period from January 2017 to January 2023. Characteristics and results of patients treated with the scheme were documented. of G/P. No conflict of interest was reported by the researchers.</p></span> <span id="abss0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Results</span><p id="spara003" class="elsevierStyleSimplePara elsevierViewall">From a total of 2,397 HCV-infected patients treated with the first-line DAA scheme, without cirrhosis or with compensated cirrhosis, a total of 9 patients presented virological failure, the average age was 52.4 years, five women and four men, of these, six patients had fibrosis grade F4, 3 of them F1, the predominant genotype was 1a, the initial regimens were SOF/VEL or SOF/LED in the majority, only one case used Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir + Ribavirin, all the patients re-treated with G/P had SVR at 12 weeks, no resistance profile was routinely performed, adverse effects were mild, and were reported in 22.2% of the total, none of them abandoned treatment.</p></span> <span id="abss0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Conclusions</span><p id="spara004" class="elsevierStyleSimplePara elsevierViewall">First-line DAAs are effective; virological failure in our sample is lower (0.37%) than reported in the literature. G/P is an effective and safe scheme for retreatment of patients with failure without cirrhosis or with compensated cirrhosis (100% response in our study), without serious adverse effects, which makes it possible to eliminate and meet the WHO 2030 goals.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abss0001" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abss0002" "titulo" => "Materials and Patients" ] 2 => array:2 [ "identificador" => "abss0003" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abss0004" "titulo" => "Conclusions" ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002047/v2_202404250742/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000029000000S2/v2_202404250742/S1665268124002047/v2_202404250742/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002047?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 6 | 5 | 11 |
2024 September | 19 | 9 | 28 |
2024 August | 17 | 5 | 22 |
2024 July | 5 | 4 | 9 |
2024 June | 14 | 6 | 20 |
2024 May | 15 | 11 | 26 |
2024 April | 19 | 15 | 34 |
2024 March | 16 | 12 | 28 |